BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 6944597)

  • 21. [Comparative evaluation of various methods of treating acute leukemia].
    Khvatova NV; Lorie IuI; Solov'eva EA; Frenkel' MA
    Ter Arkh; 1971 May; 43(5):3-7. PubMed ID: 5286868
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of acute granulocytic leukemias with daunomycin].
    Eur J Cancer (1965); 1969 Sep; 5(4):339-42. PubMed ID: 5259625
    [No Abstract]   [Full Text] [Related]  

  • 23. [Use of rubomycin in the treatment of children with acute leukemia].
    Alekseev NA
    Probl Gematol Pereliv Krovi; 1975 Oct; 20(10):45-8. PubMed ID: 1060060
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of acute granulocytic leukoses with daunomycin: 14 cases].
    Giralt M; Torres A; Raichs A
    Sangre (Barc); 1969; 14(3):309-17. PubMed ID: 5288843
    [No Abstract]   [Full Text] [Related]  

  • 25. A comparison of the in vitro cytotoxicity of daunorubicin and liposomal daunorubicin in pediatric acute leukemia.
    Goemans BF; Zwaan CM; Reinhardt D; Gibson BE; Hählen K; Kaspers GJ
    Haematologica; 2006 Nov; 91(11):1573-4. PubMed ID: 17043024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Results obtained with the clinical use of adriamycin].
    Esposito S; Taylor LA
    Haematologica; 1971; 56(9):343-66. PubMed ID: 5004536
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cytochemical modifications in the blood of patients with acute leukemia treated with daunomycin, vincristine and cortisone].
    La Grutta A; Lo Curto M
    Haematologica; 1969; 54(7):472-82. PubMed ID: 4986882
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical-pharmacological study on a new combination therapy in acute blastic leukemia in the adult].
    Obrecht P; Meuret G
    Haematol Lat; 1969; 12(3):799-807. PubMed ID: 5273186
    [No Abstract]   [Full Text] [Related]  

  • 29. Daunorubicin in the treatment of adult acute leukaemia.
    Burgess MA; Garson OM; de Gruchy GC
    Med J Aust; 1970 Mar; 1(13):629-35. PubMed ID: 5267172
    [No Abstract]   [Full Text] [Related]  

  • 30. Preliminary results in secondary acute non-lymphocytic leukemia (ANLL) treated with Idarubicin.
    Parmentier C; Finaud M; Schlumberger M; Morardet N; Berger R; Bayle C; Carde P; Hurteloup P; Hayat M
    Nouv Rev Fr Hematol (1978); 1985; 27(6):393-5. PubMed ID: 3867854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cytosine arabinoside in the therapy of acute leukoses].
    Quaglino D; De Pasquale A; Curci G; Montero C; Piccinini L
    Minerva Med; 1971 Jun; 62(45):2271-82. PubMed ID: 5281484
    [No Abstract]   [Full Text] [Related]  

  • 32. Daunorubicin in acute leukaemia.
    Souhami RL; Prankerd TA
    Postgrad Med J; 1970 May; 46(535):272-5. PubMed ID: 5270679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Early daunorubicin cardiotoxicity and fatal outcome in a child with acute myeloblastic leukemia (M2)].
    Rizzari C; Santamaria M; Galli MA; Jankovic M; Uderzo C
    Pediatr Med Chir; 1987; 9(6):749-50. PubMed ID: 3481847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Carminomycin in the therapy of leukemias].
    Vygovskaia IaI; Mazurok AA; Kondrat'eva NA; Orel VG
    Antibiotiki; 1982 Aug; 27(8):632-5. PubMed ID: 6957161
    [No Abstract]   [Full Text] [Related]  

  • 35. [Acute promyelocytic leukemia. Analysis and results of treatment with daunorubicin in 29 patients].
    Jarque I; Sanz MA; Martín-Aragonés G; Martínez J; Rafecas FJ; Sanz GF; Lorenzo JI; Sayas MJ; Gomis F; Marty ML
    Sangre (Barc); 1986; 31(4):411-24. PubMed ID: 3466374
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of 30 adult patients with acute lymphoblastic leukemia].
    Nagura E; Kawashima K; Suzuki H; Kato Y; Ono R; Yamada K; Yokomaku S; Morita A; Nishiwaki H
    Rinsho Ketsueki; 1982 Oct; 23(10):1533-9. PubMed ID: 6961242
    [No Abstract]   [Full Text] [Related]  

  • 37. [Trial of treatment of acute lymphoblastic and myeloblastic leukemias by a new antibiotic: rubidomycin (RP 13,057). Study of 61 cases].
    Bernard J; Jacquillat C; Boiron M; Najean Y; Seligmann M; Tanzer J; Weil M; Lortholary P
    Presse Med (1893); 1967 Apr; 75(19):951-5. PubMed ID: 5229352
    [No Abstract]   [Full Text] [Related]  

  • 38. [L-asparaginase in the treatment of acute leukoses].
    Storti E; Fontana G; Ascari E; Lusvarghi E; Silingardi V; Quaglino D; Sgandurra A; Barbieri U; Traldi A
    Minerva Med; 1970 Sep; 61(71):3635-42. PubMed ID: 5271737
    [No Abstract]   [Full Text] [Related]  

  • 39. [Detection of cardiotoxic effect of rubidomycin under clinical conditions].
    Eichelkraut A; Orłowska-Westwood B; Polakowski P
    Pol Tyg Lek; 1981 May; 36(19):657-9. PubMed ID: 6943517
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiac ultrastructural changes induced by daunorubicin therapy.
    Buja LM; Ferrans VJ; Mayer RJ; Roberts WC; Henderson ES
    Cancer; 1973 Oct; 32(4):771-88. PubMed ID: 4270890
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.